Carregant...
Heart Failure in Relation to Tumor-Targeted Therapies and Immunotherapies
Tumor-targeted therapies such as trastuzumab have led to significant improvements in survival of human epidermal growth factor receptor 2 (HER2)-positive breast cancer. However, these therapies have also been associated with significant left ventricular dysfunction. The incidence of trastuzumab-indu...
Guardat en:
| Publicat a: | Methodist Debakey Cardiovasc J |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
The Methodist Hospital Houston, Texas
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6977568/ https://ncbi.nlm.nih.gov/pubmed/31988685 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14797/mdcj-15-4-250 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|